DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signatures

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Thomson, John P ^a   Fawkes, Angie ^b   Ottaviano, Raffaele ^a   Hunter, Jennifer M ^a   Shukla, Ruchi ^a   Mjoseng, Heidi K ^a   Clark, Richard ^b   Coutts, Audrey ^b   Murphy, Lee ^b   Meehan, Richard R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANIMAL; DNA METHYLATION; EPIGENETICS; GENETIC EPIGENESIS; GENOME-WIDE ASSOCIATION STUDY; HIGH THROUGHPUT SEQUENCING; IMMUNOPRECIPITATION; LIVER; METABOLISM; MOUSE; PROCEDURES;

ANIMALS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; IMMUNOPRECIPITATION; LIVER; MICE;

EID: 84929589974     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09778     Document Type: Article

References (34)

1. Sarda, S. & Hannenhalli, S. Next-Generation Sequencing and Epigenomics Research: A Hammer in Search of Nails. Genomics Inform 12, 2-11 (2014).
2. Ecker, J. R. et al. Genomics: ENCODE explained. Nature 489, 52-55 (2012).
3. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007).
4. Song, C. X. et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29, 68-72 (2011).
5. Thomson, J. P. et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464, 1082-1086 (2010).
6. Rothberg, J. M. et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 475, 348-352 (2011).
7. Nawy, T. Speed-reading DNA in the dark. Nat. Methods 8, 708-709 (2011).
8. Cheng, C. S. et al. Semiconductor-based DNA sequencing of histone modification states. Nat. Commun. 4, 2672 (2013).
9. Thomson, J. P. et al. Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques. Nucleic Acids Res. 41, e206 (2013).
10. Ficz, G. & Gribben, J. G. Loss of 5-hydroxymethylcytosine in cancer: cause or consequence? Genomics (2014).
11. Laird, A., Thomson, J. P., Harrison, D. J. & Meehan, R. R. 5-hydroxymethylcytosine profiling as an indicator of cellular state. Epigenomics 5, 655-669 (2013).
12. Globisch, D. et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 5, e15367 (2010).
13. Song, C. X., Yi, C. & He, C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat. Biotechnol. 30, 1107-1116 (2012).
14. Song, C. X. & He, C. Balance of DNA methylation and demethylation in cancer development. Genome Biol. 13, 173 (2012).
15. Booth, M. J. et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336, 934-937 (2012).
16. Yu, M. et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149, 1368-1380 (2012).
17. Nestor, C. E. & Meehan, R. R. Hydroxymethylated DNA immunoprecipitation (hmeDIP). Methods Mol. Biol. 1094, 259-267 (2014).
18. Cui, L., Chung, T. H., Tan, D., Sun, X. & Jia, X. Y. JBP1-seq: A fast and efficient method for genome-wide profiling of 5hmC. Genomics 104, 368-375 (2014).
19. Pastor, W. A., Huang, Y., Henderson, H. R., Agarwal, S. & Rao, A. The GLIB technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat. Protoc. 7, 1909-1917 (2012).
20. Huang, Y., Pastor, W. A., Zepeda-Martinez, J. A. & Rao, A. The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat. Protoc. 7, 1897-1908 (2012).
21. Matarese, F., Carrillo-de Santa Pau, E. & Stunnenberg, H. G. 5-Hydroxymethylcytosine: a new kid on the epigenetic block? Mol. Syst. Biol. 7, 562 (2011).
22. Nestor, C. E., Reddington, J. P., Benson, M. & Meehan, R. R. Investigating 5-hydroxymethylcytosine (5hmC): the state of the art. Methods Mol. Biol. 1094, 243-258 (2014).
23. Thomson, J. P. et al. Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol. 13, R93 (2012).
24. Quackenbush, J. Microarray data normalization and transformation. Nat. Genet. 32 Suppl, 496-501 (2002).
25. Ficz, G. et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402 (2011).
26. Nestor, C. E. et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 22, 467-477 (2012).
27. Thomson, J. P. et al. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res. 41, 5639-5654 (2013).
28. Thomson, J. P., Moggs, J. G., Wolf, C. R. & Meehan, R. R. Epigenetic profiles as defined signatures of xenobiotic exposure. Mutat. Res. 764-765, 3-9 (2014).
29. Neri, F. et al. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol. 14, R91 (2013).
30. Wang, T. et al. Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat. Cell Biol. 15, 700-711 (2013).
31. Polo, J. M. et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617-1632 (2012).
32. Pujadas, E. & Feinberg, A. P. Regulated noise in the epigenetic landscape of development and disease. Cell 148, 1123-1131 (2012).
33. Rivera, C. M. & Ren, B. Mapping human epigenomes. Cell 155, 39-55 (2013).
34. Sproul, D. & Meehan, R. R. Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct. Genomics 12, 174-190 (2013).